Related Experiment Video

Updated: May 19, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Genetic and biochemical alterations in non-small cell lung cancer

Jackie L Johnson1, Smitha Pillai, Srikumar P Chellappan

  • 1Cancer Biology Ph.D. Program, University of South Florida, Tampa, FL 33612, USA.

Biochemistry Research International
|August 29, 2012
PubMed

Insights

Targeted therapies are revolutionizing non-small-cell lung cancer (NSCLC) treatment by focusing on specific genetic mutations. Understanding these molecular targets, including key protein alterations, is crucial for developing effective lung cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer remains a leading cause of cancer mortality despite treatment advances.
  • Genetic alterations in tumors drive non-small-cell lung cancer (NSCLC) development.
  • Understanding molecular pathways is key to novel therapeutic strategies.

Purpose of the Study:

  • To elucidate the molecular targets in non-small-cell lung cancer (NSCLC).
  • To describe the biological significance of various mutations.
  • To assess the potential of these mutations as therapeutic targets.

Main Methods:

  • Review of recent advances in genetic alteration detection.
  • Analysis of physiologically relevant animal models.
  • Examination of disrupted cell signaling pathways in NSCLC.

Main Results:

  • Identified key mutations in growth regulatory proteins (e.g., K-Ras, EGFR, ALK) and tumor suppressors (e.g., TP53, PTEN).
  • Highlighted the heterogeneity of signaling pathway disruption in NSCLC.
  • Emphasized the importance of understanding pathway differences between smokers and non-smokers.

Conclusions:

  • Molecular profiling of NSCLC tumors reveals critical therapeutic targets.
  • Targeted therapies offer potent and specific treatment options for NSCLC.
  • Further research into smoking-related pathway differences can refine treatment strategies.

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN11:50

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN

Published on: April 3, 2026

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mutations01:39

Mutations

Overview
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...